HYPERTHERMIA INDUCES ERYPTOSIS IN HEREDITARY SPHEROCYTOSIS

EHA Library, Renee Crisp, 53991

WT1-ASSOCIATED MISSPLICING IN ACUTE MYELOID LEUKEMIA

EHA Library, Eric Wattel, 53526

PROGNOSTIC SIGNIFICANCE OF THE MRC CYTOGENETIC CLASSIFICATION COMPARED WITH THE EUROPEAN LEUKEMIANET (ELN) GENETIC RISK CLASSIFICATION SYSTEM IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Tapan Kadia, 53525

EXPRESSION OF THE IMMUNOGLOBULIN SUPERFAMILY CELL MEMBRANE ADHESION MOLECULE CD146 IN ACUTE LEUKEMIA

EHA Library, Francesco Cavazzini, 53590

PROPENSITY SCORE MATCHED COMPARISON OF INTERMEDIATE INTENSITY CHEMOTHERAPY INDUCTION VERSUS INTENSIVE CHEMOTHERAPY INDUCTION IN ELDERLY PATIENTS (AGES 60 YEARS OR OLDER) WITH AML

EHA Library, Koichi Takahashi, 53524

EARLY PERIPHERAL BLAST CELL CLEARANCE ASSESSED BY FLOW CYTOMETRY IN INDUCTION IS A NOVEL POWERFUL PROGNOSTIC INDICATOR IN ACUTE MYELOID LEUKEMIA: A NORTHERN ITALY LEUKEMIA GROUP (NILG) STUDY

EHA Library, Francesco Mannelli, 53523

CORRELATIONS OF EXPOSURE AND RESPONSE FOR INOTUZUMAB OZOGAMICIN IN PATIENTS WITH RELAPSED OR REFRACTORY, CD22-POSITIVE ADULT ACUTE LYMPHOCYTIC LEUKEMIA

EHA Library, Kenneth T. Luu, 53588

MITOGEN-STIMULATED DIRECT ANTIGLOBULIN TEST IN PATIENTS WITH HEREDITARY SPHEROCYTOSIS

EHA Library, Anna Zaninoni, 53988

ECTOPIC EXPRESSION OF THE HEDGEHOG PATHWAY LIGANDS SHH AND IHH IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL)

EHA Library, Antonis Dagklis, 53522

NEGATIVE OUTCOME IN PTEN MUTATED ACUTE LYMPHOBLASTIC LEUKEMIA PEDIATRIC PATIENTS COULD BE MODULATED BY THE PRESENCE OF NOTCH1/FBXW7 MUTATIONS

EHA Library, Mireia Camós, 53587

GENETIC MARKERS AND FETAL HEMOGLOBIN (HBF) PRODUCTION: ASSOCIATION STUDY IN DELTABETA THALASSEMIA

EHA Library, Felix De La Fuente Gonzalo, 53987

CATION LEAK ANALYSIS OF ABCB6 MUTANTS IN FAMILIAL PSEUDOHYPERKALEMIA

EHA Library, Immacolata Andolfo, 53986

FUNCTIONAL STUDIES OF IK6 EXPRESSION SHED LIGHT ON THE COOPERATING MECHANISMS UNDERLYING THE GAIN OF MALIGNANCY IN B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA

EHA Library, Nahid Zareian, 53520

TELOMERE DNA CONTENT AND TP53 STATE PROVIDE AN INSIGHT INTO GENOMIC INSTABILITY IN OLDER ADULT PATIENTS WITH ALL

EHA Library, Ghada Zakout, 53519

THE SPECTRUM OF ADULT'S PARVOVIRUS B19 INFECTION IN HOSPITAL ACCORDING TO THE CLINICAL BACKGROUND: REPORT OF A SINGLE CENTER EXPERIENCE AND PROPOSALS FOR THE CLINICAL PRACTICE.

EHA Library, Orianne Wagner-Ballon, 53984

ROLE OF THE HYSTONE DEACETYLASE INHIBITOR GIVINOSTAT (ITF2357) IN TREATMENT OF CRLF2 REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Angela Maria Savino, 53518

PROGNOSTIC IMPACT OF IKZF1 DELETIONS IN PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA TREATED ACCORDING TO NOPHO PROTOCOLS – THE SWEDISH EXPERIENCE

EHA Library, Ingegerd Ivanov Ofverholm, 53583

INVESTIGATION OF PH-LIKE ALL BY GENE SET ENRICHMENT ANALYSIS AND IDENTIFICATION OF THEIR SPECIFIC EXPRESSION GENES

EHA Library, Kazutoshi Iijima, 53517

THE INDEPENDENT PROGNOSTIC VALUE OF IKZF1-DELETION IN CHINESE ADULT COMMON B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND THE SUPERIORITY OF STEM CELL TRANSPLANTATION OVER CHEMOTHERAPY FOR IKZF1 DELETED PATIENTS

EHA Library, Guo-Rui Ruan, 53582

EVALUATION OF TP53 MUTATIONS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): RESULTS FROM IRON (INTERLABORATORY ROBUSTNESS OF NEXT-GENERATION SEQUENCING) II STUDY

EHA Library, Ilaria Bronzini, 53516

SIGNIFICANCE OF MRD BY BCR-ABL QUANTITATIVE PCR DURING COMBINATION TREATMENT WITH VARIOUS TKIS PLUS CHEMOTHERAPY FOLLOWED BY ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR PH-POSITIVE ADULT ALL

EHA Library, Dae-Young Kim, 53581

MODIFIED ACTRIIB-FC FUSION PROTEIN (ACE-536) AMELIORATES ANEMIA IN A MODEL OF SICKLE CELL DISEASE

EHA Library, Rajasekhar NVS Suragani, 53981

DARATUMUMAB TREATMENT ALONE OR IN COMBINATION WITH VINCRISTINE RESULTS IN THE INHIBITION OF TUMOR GROWTH AND LONG TERM SURVIVAL IN PRECLINICAL MODELS OF ACUTE LYMPHOCYTIC LEUKEMIA

EHA Library, Parul Doshi, 53515

NON-INTENSIVE, BUT NO-INTERRUPTIONS PROTOCOL PROVIDES COMPARABLE RESULTS IN AYA AND OLDER ADULTS WITH PH-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: THE RUSSIAN ACUTE LYMPHOBLASTIC LEUKEMIA (RALL) STUDY GR

EHA Library, Elena Parovichnikova, 53580

INTERACTIONS BETWEEN MULTIPOTENT MESENCHYMAL STROMAL CELLS AND HEMATOPOIETIC PROGENITOR CELLS ALTER AFTER INTERLEUKIN 1 BETA ADMINISTRATION

EHA Library, Nina Drize, 53980

REVEALING EXPRESSION, POST-TRANSLATIONAL MODIFICATIONS AND PROTEOLYSIS IN CHILDHOOD ACUTE LEUKEMIA USING A NOVEL FLOW CYTOMETRY-BASED METHOD OF AFFINITY PROTEOMICS

EHA Library, Daniela Kuzilkova, 53513

CMYC-TRANSLOCATIONS IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Roberta LA STARZA, 53512

THE FIRST LNCRNA LANDSCAPE OF MAJOR GENETIC T-ALL SUBSETS AND GUILT-BY-ASSOCIATION ANALYSIS FOR IMMATURE T-ALL SPECIFIC LNCRNAS

EHA Library, Annelynn Wallaert, 53510

IMPACT OF VIRUSES ON THE PATHOGENESIS OF SPORADIC CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA: INTEGRATION AND PRESENCE OF 25.525 VIRAL GENOMES TESTED BY NEXT GENERATION SEQUENCING

EHA Library, Ute Fischer, 53509

INTRA-PATIENT CLONAL AND SUBCLONAL HETEROGENEITY OF CHRONIC LYMPHOCYTIC LEUKEMIA: EVIDENCES FROM CIRCULATING AND LYMPH NODAL COMPARTMENTS

EHA Library, Ilaria Del Giudice, 53649

TARGETING NOTCH2 SIGNALING BY GLIOTOXIN INDUCES APOPTOSIS IN CLL CELLS BY A MECHANISM INVOLVING NOTCH3 AND NR4A1

EHA Library, Rainer Hubmann, 53651

IMMUNOHISTOCHEMICAL ANALYSIS OF IL-6, IL-8/CXCR2 AXIS, TYROSINE P-STAT–3 AND SOCS-3 IN CLL LYMPH NODES: CORRELATION WITH MICROVASCULAR CHARACTERISTICS, CLINICAL FEATURES AND PROGNOSIS

EHA Library, Sotirios Sachanas, 53652

EXPRESSION AND FUNCTIONAL ACTIVITY OF THE TNFR-SUPERFAMILY MEMBER DEATH RECEPTOR 3 IN CHRONIC LYMPHOCYTIC LEUKEMIA B CELLS ACTIVATED BY THE BCR

EHA Library, Chiara Cavallini, 53653

VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INCREASES CELL MIGRATION THROUGH INTERACTION WITH THE CXCR4/SDF1 AXIS IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL)

EHA Library, Sandra Ballester Garcia, 53654

ANALYSIS OF IMMUNOGLOBULIN GENE REARRANGEMENTS IN CHINESE AND ITALIAN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Marilisa Marinelli, 53655

SRC INHIBITORS DOWNREGULATE CD20 AND MODULATE THE ACTIVITY OF THE CD20 PROMOTER

EHA Library, Magdalena Winiarska, 53657

COMPLEX ACTIVATION OF ANGIOGENIC SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA: EVIDENCE FROM CIRCULATING ANGIOGENIC CYTOKINES.

EHA Library, Lukáš Smolej, 53658

CHRONIC LYMPHOCYTIC LEUKEMIA CELL CAPACITY OF EXPRESSING AND RESPONDING TO SURFACE IGM (S-IGM) OR S-IGD PREDICTS DISEASE PROGRESSION AND IS ASSOCIATED WITH SPECIFIC MIRNA/MRNA SIGNATURES

EHA Library, Fortunato Morabito, 53659

NICHEFORMING STROMAL ELEMENTS OF BONE MARROW AND LYMPH NODES IN CLL

EHA Library, Natalya Semenova, 53661

DISTRIBUTION OF CIRCULATING RESIDUAL NORMAL B-CELLS AND OTHER IMMUNE CELLS IN ADVANCED-STAGE B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) ACCORDING TO THE NUMBER OF PRIOR TREATMENT LINES RECEIVED

EHA Library, Susana Barrena, 53662

THE INFLUENCE OF BENDAMUSTINE USED ALONE OR IN COMBINATION WITH RITUXIMAB ON APOPTOSIS AND THE EXPRESSION OF SOME APOPTOSIS-REGULATING PROTEINS DEPENDING ON THE IGVH MUTATIONAL STATUS OF CLL CELLS

EHA Library, Anna Korycka-Wolowiec, 53663

DECREASED DKK-1 LEVELS IN CHRONIC LYMPHOCYTIC LEUKEMIA AT INITIAL DIAGNOSIS MIGHT BE PREDICTIVE OF A HIGHER MORTALITY

EHA Library, Gulsum Pamuk, 53664

MRD ANALYSIS IN BONE MARROW ASPIRATE AT 3 MONTHS AFTER TREATMENT IS THE OPTIMAL RESPONSE ASSESSMENT FOR CLL AND CAN PREDICT SUSTAINED MRD-NEGATIVE REMISSION INDEPENDENT OF ADVERSE PROGNOSTIC MARKERS

EHA Library, Andy Rawstron, 53665

NOT ALL IGHV3-21 CLL ARE EQUAL: SUBSET #2 DISPLAYS A DISTINCTIVE CLINICOBIOLOGICAL PROFILE WITH REMARKABLE SIMILARITIES TO SUBSET #169, ITS CLOSE IMMUNOGENETIC RELATIVE

EHA Library, Panagiotis Baliakas, 53666

IMMUNOGLOBULIN HEAVY VARIABLE GENES AND ALLELES: NEW ENTITIES, NEW NAMES AND IMPLICATIONS FOR RESEARCH AND PROGNOSTICATION IN CLL

EHA Library, Aliki Xochelli, 53667

FcγRIIb inhibits BCR signaling in human normal B cells but its function is impaired in CLL cells

EHA Library, Rosa Bosch, 53670

INDIRECT INDUCTION OF REGULATORY T CELLS ACCOMPANIES IMMUNE RESPONSES DURING VACCINATION OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH SHORT, RHAMM-DERIVED, MHC-I- RESTRICTED PEPTIDE

EHA Library, Joanna Zaleska, 53672

IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF TUMOR SPECIFIC ANTIBODY RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Valentina Griggio, 53675

THE GENE EXPRESSION RESPONSE TO INTERLEUKIN-4 AND ITS DIFFERENTIAL MODULATION BY NFKB CORRELATE WITH ZAP70 IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Antonio Parrado, 53678

SKEWING OF THE T-CELL RECEPTOR REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: WHAT LIES BENEATH?

EHA Library, Anna Vardi, 53647

DEVELOPMENT AND VALIDATION OF COMPREHENSIVE CLL MUTATION DETECTION PANEL USING ION TORRENT NEXT GENERATION SEQUENCING PLATFORM

EHA Library, Gerard Lozanski, 53680

PHASE 1 STUDY OF SINGLE AGENT CC-292, A HIGHLY SELECTIVE BRUTON\'S TYROSINE KINASE (BTK) INHIBITOR, IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, Jennifer R. Brown, 53681

LATE ONSET NEUTROPENIA IS A COMMON COMPLICATION OF FLUDARABINE, CYCLOPHOSPHAMIDE AND RITUXIMAB (FCR) THERAPY AND IS ASSOCIATED WITH SUBSTANTIAL MORBIDITY AND HOSPITALIZATION

EHA Library, Prahlad Ho, 53684

Beta-2-MICROGLOBULIN IS A DYNAMIC MARKER OF PROGNOSIS DURING TREATMENT OF CLL WITH FCR OR IBRUTINIB-BASED REGIMENS.

EHA Library, Philip Thompson, 53686

FIRST-LINE TREATMENT STRATEGIES FOR PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA: PRELIMINARY RESULTS OF A NETWORK META-ANALYSIS

EHA Library, Michaela Rancea, 53687

CHRONIC LYMPHOCYTIC LEUKEMIA: A SMALL PROPORTION OF LONG-TERM SURVIVORS COULD ACTUALLY BE CURED.

EHA Library, Carol Moreno, 53688

RICHTER'S TRANSFORMATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): ANALYSIS OF BIOLOGICAL AND CLINICAL RISK FACTORS AND OUTCOMES

EHA Library, Edwin Gershom, 53689

INTERIM RESULTS FROM A PHASE IIA STUDY OF THE ANTI-CXCL12 SPIEGELMER OLAPTESED PEGOL (NOX-A12) IN COMBINATION WITH BENDAMUSTINE/RITUXIMAB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Kai Riecke, 53690

A SYSTEMATIC REVIEW AND EVIDENCE SYNTHESIS OF RANDOMISED CONTROLLED TRIALS (RCT) FOR THE TREATMENT OF RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, Joan Quigley, 53691

PROSPECTIVE VALIDATION OF A RISK SCORE BASED ON BIOLOGICAL MARKERS FOR PREDICTING PFS IN BINET STAGE A CLL PATIENTS: RESULTS OF THE MULTICENTER O-CLL1-GISL STUDY

EHA Library, Massimo Gentile, 53692

SALVAGE TREATMENT WITH BENDAMUSTINE, OFATUMUMAB, HIGH-DOSE METHYLPREDNISOLONE (BOMP) IN HIGH-RISK R/R CLL : INTERIM RESULTS OF THE FRENCH CLL INTERGROUP (GCFLLC/MW - GOELAMS) ICLL01 PHASE 2 TRIAL.

EHA Library, Olivier TOURNILHAC, 53693

NOVEL GENE MUTATIONS IN CHINESE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

EHA Library, Yi Xia, 53694

THE ROLE OF ALLOGENEIC STEM-CELL TRANSPLANTATION FOR RICHTER'S SYNDROME - META-ANALYSIS

EHA Library, Darko Antic, 53697

BLOOD STREAM INFECTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA: STABLE DISTRIBUTION BUT WITH INCREASED MORTALITY RATE?

EHA Library, Christian Kjellander, 53699

TARGETING OF STAT3 AND STAT5 BY A NOVEL DRUG- COMBINATION EMPLOYING PONATINIB AND BARDOXOLONE METHYL (CDDO-ME) LEADS TO SYNERGISTIC EFFECTS IN BCR/ABL-T315I-MUTATED CELLS IN PH+ CML

EHA Library, Karoline V. Gleixner, 53700

LASP1 IS A NOVEL BCR-ABL SUBSTRATE AND A PHOSPHORYLATION-DEPENDENT BINDING PARTNER OF CRKL IN CHRONIC MYELOID LEUKEMIA

EHA Library, Jochen Frietsch, 53702

MYELOID DERIVED SUPPRESSOR CELLS (MDSCS) AS POTENTIAL IMMUNE ESCAPE MECHANISM IN CML PATIENTS

EHA Library, Cesarina Giallongo, 53704

BIN1 AND RIN1 MODULATION IN CHRONIC MYELOID LEUKEMIA

EHA Library, Stefania Trino, 53705

PROMOTER METHYLATION OF THE TUMOR SUPPRESSOR GENES ON THE SHORT ARM OF CHROMOSOME 1 IN CHRONIC MYELOGENOUS LEUKEMIA

EHA Library, Naoki Mori, 53706

BONE MARROW (BM) MICROENVIROMENT FACTORS AS EARLY MARKERS OF RESPONSE IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA (CML-CP) TREATED WITH NILOTINIB.

EHA Library, Concetta Quintarelli, 53707

IMPACT OF CLONAL EVOLUTION ON THE OVERALL SURVIVAL OF PATIENTS WITH CML TREATED WITH IMATINIB: EXPERIENCE OF ONE CENTER

EHA Library, Kostyantyn KOTLYARCHUK, 53709

A FUNCTIONAL POLYMORPHISM IN THE 3' UNTRANSLATED REGION OF THE ARHGAP26 GENE CONFERS AN INCREASED RISK OF CHRONIC MYELOID LEUKEMIA AND CAUSES ILLEGITIMATE REGULATION BY MICRORNA-18A-3P

EHA Library, Agnieszka Dzikiewicz-Krawczyk, 53710

PHARMACOGENETIC DETERMINANTS OF PLASMATIC AND INTRACELLULAR TYROSINE KINASE INHIBITORS

EHA Library, Carmen Fava, 53711

THE COMBINATION OF PANOBINOSTAT AND PONATINIB EXERTS SYNERGISTIC CYTOTOXICITY IN IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA CELL LINES INCLUDING BCR-ABL GENE MUTATION WITH T315I

EHA Library, Yasufumi Matsuda, 53713

GENE EXPRESSION PROFILING OF CD34+/LIN- CELLS OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA AT DIAGNOSIS IDENTIFIES NEW GENES RELATED TO THE NUMBER OF CD34+/LIN- CELLS DURING NILOTINIB TREATMENT

EHA Library, Alessandra Trojani, 53714

EXPRESSION LEVELS OF CERAMIDE-GENERATING AND CLEARANCE GENES IN NEWLY DIAGNOSED AND TYROSINE KINASE INHIBITOR-RESISTANT CHRONIC MYELOID LEUKEMIA PATIENTS: AN ATTEMPT TO FIND NOVEL TARGETS

EHA Library, Melis Kartal Yandim, 53715

ANTILEUKEMIC EFFECT OF PLK INHIBITOR AND IN COMBINATION WITH ABL TYROSINE KINASE INHIBITORS AGAINST BCR-ABL-POSITIVE CELLS

EHA Library, Seiichi Okabe, 53717

TYROSINE KINASE INHIBITORS DO NOT AFFECT EXPRESSION OF DNA METHYLTRANSFERASES AND GLOBAL METHYLATION LEVEL IN CHRONIC MYELOID LEUKEMIA CELLS

EHA Library, Tomasz Stoklosa, 53719

NEW MOLECULAR MARKERS OF CML PROGRESSION

EHA Library, Vsevolod Misyurin, 53723

PROGNOSIS FOR CML PATIENTS WITH >10% BCR-ABL AFTER 3 MONTHS OF IMATINIB DEPENDS ON THE INITIAL RATE OF BCR-ABL DECLINE

EHA Library, Susan Branford, 53724

NGS-ASSISTED DNA-BASED DIGITAL QPCR FOR THE DETECTION AND QUANTIFICATION OF RESIDUAL DISEASE IN CML PATIENTS WITH UNDETECTABLE BCR-ABL1 TRANSCRIPTS

EHA Library, Alikian Mary, 53726

VERY EARLY MOLECULAR RESPONSES IN THE FIRST TWO MONTHS OF THERAPY ARE HIGHLY PREDICTIVE OF DEEP MOLECULAR RESPONSES AT 18 MONTHS, IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED UPFRONT WITH NILOTINIB.

EHA Library, Valentin Garcia-Gutierrez, 53727

THE DECLINE OF BCR-ABL/GUS RATIO IN CML PATIENTS TREATED UPFRONT WITH NILOTINIB SHOWS A RAPID DESCENT DURING THE FIRST TRIMESTER, AND THE RESPONSES ARE SIMILAR TO THOSE ACHIEVED WITH ABL AS CONTROL

EHA Library, Valentin Garcia-Gutierrez, 53728

AGE AND DIGITAL-PCR ANALYSIS PREDICT RELAPSES OF CML PATIENTS FOLLOWING PROGRAMMED IMATINIB INTERRUPTION IN Q-RT-PCR NEGATIVE CHRONIC MYELOID LEUKEMIA PATIENTS

EHA Library, Silvia Mori, 53729

EARLY RESPONSE OF RADOTINIB THERAPY MAY PREDICT LONG-TERM OUTCOMES IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH RESISTANCE OR INTOLERANCE TO BCR-ABL1 TKIS: 24 MONTH UPDATE OF PHASE 2 TRIAL

EHA Library, Sung-Hyun Kim, 53730

MR4.5 AT POST-TRANSPLANT 3 MONTHS WAS A PREDICTIVE FACTOR FOR LONG-TERM OUTCOMES IN THE PATIENTS UNDERWENT ALLOGENEIC SCT IN CML CP

EHA Library, Sung-Eun Lee, 53731

MOLECULAR MONITORING USING PERIPHERAL BLOOD COMBINED WITH BONE MARROW AT 3 MONTHS OR 6 MONTHS PROVIDES A BETTER PREDICTOR OF OUTCOMES FOR PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Jiang Qian, 53732

BCR-ABL1 RATIO LOG REDUCTION IS A BETTER PREDICTOR OF MAJOR MOLECULAR RESPONSE (MMR) THAN 10% RATIO CUT-OFF AT 3 MONTHS IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS

EHA Library, Rafael Del Orbe Barreto, 53733

GENEXPERT BCR-ABL1/ABL1 MONITOR TEST (IS) FOR ROUTINE MONITORING OF CHRONIC MYELOID LEUKEMIA PATIENTS

EHA Library, Gueorgui Balatzenko, 53734

CHANGES OF QUALITY OF LIFE AFTER CESSATION OF IMATINIB IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH UNDETECTABLE MOLECULAR RESIDUAL DISEASE

EHA Library, Sukjoong Oh, 53737

LENALIDOMIDE MODIFIES THE BEHAVIOR OF MESENCHYMAL STROMAL CELLS (MSC) FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES WITH 5Q- (MDS-5Q-)

EHA Library, Sandra Muntion, 53739

IMPAIRED LINEAGE PRIMING AND PROLIFERATIVE POTENTIAL OF BONE MARROW MESENCHYMAL STEM CELLS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES ARE ASSOCIATED WITH ABNORMAL WNT SIGNALING PATHWAY

EHA Library, Charalampos Pontikoglou, 53740

DIFFERENT CLL STEREOTYPED SUBSETS, VARYING TELOMERE LENGTHS: A MEASURE OF DISTINCT PROLIFERATIVE HISTORIES LINKED WITH UNIQUE CLINICOBIOLOGICAL FEATURES

EHA Library, Kostas Stamatopoulos, 53646

LENALIDOMIDE INDUCES A PRO-INFLAMMATORY PHENOTYPE IN NURSE-LIKE CELLS DERIVED FROM CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Stefania Fiorcari, 53644

HIGH LEVEL OF COBLL1, A NOVEL ROR1 BINDING PARTNER, IDENTIFIES CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS WITH MUTATED IGHV

EHA Library, Hana Plešingerová, 53641

INCIDENCE AND MANAGEMENT OF VENOUS THROMBOSIS IN ACUTE LEUKEMIA: A MULTICENTER STUDY

EHA Library, Giorgia Saccullo, 53637

FRONTLINE TREATMENT WITH INTENSIVE CHEMOTHERAPY, AZACITIDINE OR BEST SUPPORTIVE CARE IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA: A POPULATION-BASED ANALYSIS FROM A REGIONAL HEALTHCARE NETWORK

EHA Library, Pierre Bories, 53636

PHASE I STUDY OF OPB-51602, AN INHIBITOR OF STAT3 PHOSPHORYLATION, IN PATIENTS WITH RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES

EHA Library, Yasuhito Terui, 53631

ORAL FCR INDUCES HIGHER COMPLETE REMISSION RATES AND MRD NEGATIVITY IN UNTREATED CLL THAN PREVIOUS REPORTS OF INTRAVENOUS THERAPY: COMBINED RESULTS OF THE NCRI ADMIRE AND ARCTIC TRIALS

EHA Library, Talha Munir, 53679